Unaudited Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended
	Aug. 31, 2014	Aug. 31, 2013	Aug. 31, 2014	Aug. 31, 2013
Income Statement [Abstract]
Revenue
Operating Expenses
General & administrative	1,211,176	700,826	1,802,677	2,001,467
Research & development	479,635	45,000	732,717	144,715
Total Operating Expenses	1,690,811	745,826	2,535,394	2,146,182
Other Expense (Income)
Interest expense	20,614	34,750	79,287	63,550
Accretion expense	197,246	189,324	539,319	363,306
Deferred financing costs amortization	15,131		60,523
Other income	(522)		(3,159)	(61)
Beneficial conversion feature	2,324,760		2,324,760
Total Other Expenses (Income)	2,557,229	224,074	3,000,730	426,795
NET LOSS	$ (4,248,040)	$ (969,900)	$ (5,536,124)	$ (2,572,977)
Basic & Diluted Net Loss Per Share	$ (0.17)	$ (0.05)	$ (0.23)	$ (0.12)
Weighted shares outstanding	25,542,296	21,300,995	23,582,554	21,300,995